share_log

TD Cowen Maintains Buy on Medpace Hldgs, Lowers Price Target to $372

Benzinga ·  Oct 23 19:16  · Ratings

TD Cowen analyst Charles Rhyee maintains Medpace Hldgs (NASDAQ:MEDP) with a Buy and lowers the price target from $413 to $372.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment